ALLEN; John Gordon

Patent Applications and Registrations

Patent applications and USPTO patent grants for ALLEN; John Gordon.The latest application filed is for "kif18a inhibitors".

Company Profile

10.14.25

ALLEN; John Gordon - NEWBURY PARK CA
ALLEN; John Gordon - Thousand Oaks CA
Allen; John Gordon - Newbary Park CA US
Allen; John Gordon - Indianapolis IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Kif18a Inhibitors App 20220289724 - TAMAYO; Nuria A. ; et al.	2022-09-15
Kras G12c Inhibitors And Methods Of Using The Same App 20220175782 - ALLEN; John Gordon ; et al.	2022-06-09
Substituted piperazines as KRAS G12C inhibitors Grant 11,285,156 - Allen , et al. March 29, 2	2022-03-29
Kif18a Inhibitors App 20220073504 - TAMAYO; NURIA A ; et al.	2022-03-10
Kif18a Inhibitors App 20220002311 - TAMAYO; NURIA A ; et al.	2022-01-06
Apelin Polypeptides App 20210261619 - HOLDER; Jerry Ryan ; et al.	2021-08-26
KRAS G12C inhibitors and methods of using the same Grant 11,096,939 - Booker , et al. August 24, 2	2021-08-24
KRAS G12C inhibitors and methods of using the same Grant 11,090,304 - Allen , et al. August 17, 2	2021-08-17
RNAi Constructs for Inhibiting ASGR1 Expression and Methods of Use Thereof App 20210108212 - OLLMANN; Michael ; et al.	2021-04-15
Kras G12c Inhibitors And Methods Of Using The Same App 20210009577 - LANMAN; Brian Alan ; et al.	2021-01-14
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof Grant 10,870,856 - Ollmann , et al. December 22, 2	2020-12-22
Kras G12c Inhibitors And Methods Of Using The Same App 20200055845 - LANMAN; Brian Alan ; et al.	2020-02-20
Kras G12c Inhibitors And Methods Of Using The Same App 20200030324 - BOOKER; Shon ; et al.	2020-01-30
KRAS G12C inhibitors and methods of using the same Grant 10,519,146 - Lanman , et al. Dec	2019-12-31
Kras G12c Inhibitors And Methods Of Using The Same App 20190374542 - ALLEN; John Gordon ; et al.	2019-12-12
Kras G12c Inhibitors And Methods Of Using The Same App 20190343838 - Allen; John Gordon ; et al.	2019-11-14
RNAi Constructs for Inhibiting ASGR1 Expression and Methods of Use Thereof App 20190309306 - OLLMANN; Michael ; et al.	2019-10-10
Kras G12c Inhibitors And Methods Of Using The Same App 20180334454 - LANMAN; Brian Alan ; et al.	2018-11-22
Methods Of Using Cell-cycle Inhibitors To Modulate One Or More Properties Of A Cell Culture App 20180087079 - DU; Zhimei ; et al.	2018-03-29
Carbohydrate phosphonate derivatives as modulators of glycosylation Grant 9,328,134 - Allen , et al. May 3, 2	2016-05-03
Carbohydrate Phosphonate Derivatives as Modulators of Glycosylation App 20150376221 - Allen; John Gordon ; et al.	2015-12-31
Methods Of Using Cell-cycle Inhibitors To Modulate One Or More Properties Of A Cell Culture App 20150353542 - DU; Zhimei ; et al.	2015-12-10
Methods Of Using Cell-cycle Inhibitors To Modulate One Or More Properties Of A Cell Culture App 20140199728 - DU; Zhimei ; et al.	2014-07-17
6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonist Grant 8,580,780 - Allen , et al. November 12, 2	2013-11-12
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonists Grant 8,420,631 - Allen , et al. April 16, 2	2013-04-16
6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist App 20120028961 - ALLEN; JOHN GORDON ; et al.	2012-02-02
6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonists Grant 8,022,062 - Allen , et al. September 20, 2	2011-09-20
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonists Grant 7,994,163 - Allen , et al. August 9, 2	2011-08-09
Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 Grant 7,816,349 - Allen , et al. October 19, 2	2010-10-19
Cycloalkyl Lactam Derivatives As Inhibitors Of 11-beta-hydroxysteroid Dehydrogenase 1 App 20100184764 - AICHER; Thomas Daniel ; et al.	2010-07-22
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 Grant 7,713,979 - Aicher , et al. May 11, 2	2010-05-11
6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines As 5-ht2c Receptor Agonists App 20090099155 - Allen; John Gordon ; et al.	2009-04-16
Substituted Pyrrolidinones As Inhibitors Of 11-beta-hydroxysteroid Dehydrogenase 1 App 20090069326 - Allen; John Gordon ; et al.	2009-03-12
Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 App 20080275043 - Aicher; Thomas Daniel ; et al.	2008-11-06
6-Substituted-2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists App 20080255092 - Allen; John Gordon ; et al.	2008-10-16
Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 App 20080214621 - Aicher; Thomas Daniel ; et al.	2008-09-04
6-Substituted-2,3,4,5-Tetrahydro-1H-Benzo[D] Azepines as 5-Ht2c Receptro Agonists App 20080207897 - Allen; John Gordon ; et al.	2008-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.